Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Vasculitis
•
Primary Care
When advising patients on starting Avacopan for Granulomatosis with polyangiitis, what side effects do you tell patients are commonly seen in clinical practice?
Related Questions
How would you manage active psoriasis and psoriatic arthritis in patient on Rituximab and prednisone for MPO positive vasculitis?
How long do you recommend that a patient wear a mask when resuming biologic infusions following a recent upper respiratory infection?
What treatments have you found most effective for cholestatic pruritus?
Do you send anti-human neutrophil elastase antibodies when you suspect levamisole-induced ANCA vasculitis?
What therapies have you found most effective for JAK-induced/associated acne (JAKcne)?
What is your approach to work up for patients referred for early onset osteoarthritis?
How do you approach the management of a patient with RA on methotrexate who has gingivitis or or frequent cavities?
Would you recommend waiting for a low Vitamin D level to correct to goal prior to giving a scheduled Prolia injection when transitioning a patient from Zolendronic acid to Prolia therapy for worsening osteoporosis?
What is the appropriate interval to obtain a hydroxychloroquine level after making a dosage adjustment?
Would you stop romosozumab if a patient developed mild asymptomatic hypocalcemia while on treatment?
